Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesRadiation Oncology/TherapyPSMA-PET scans guide LDR brachytherapy in prostate cancerAt last follow-up, 79% of patients were without evidence of disease.BreastHalf of false-negative DBT exams are missed cancersNuclear MedicineGE HealthCare to acquire Sofie Biosciences for $945MRadiology EducationEarly exposure program introduces college students to imaging careersSponsor ContentFree Webinar: CT Contrast Injection Reimagined